Literature DB >> 25323296

Comorbidity modulates non invasive ventilation-induced changes in breath print of obstructive sleep apnea syndrome patients.

Raffaele Antonelli Incalzi1, Giorgio Pennazza, Simone Scarlata, Marco Santonico, Chiara Vernile, Livio Cortese, Elena Frezzotti, Claudio Pedone, Arnaldo D'Amico.   

Abstract

INTRODUCTION: In obstructive sleep apnea syndrome (OSAS), exhaled volatile organic compounds (VOCs) change after long-term continuous positive airway pressure (CPAP). The objective of the study was to verify whether changes in VOCs pattern are detectable after the first night of CPAP and to identify correlates, if any, of these changes.
METHODS: Fifty OSAS patients underwent a multidimensional assessment and breath print (BP) analysis through 28 sensors e-nose at baseline and after the first night of CPAP. Boxplots of individual BP evolution after CPAP and groups were compared by ANOVA and Fisher's exact t. Partial least square discriminant analysis (PLS-DA), with leave-one-out as cross-validation was used to calculate to which extent basal BP could predicts changes in apnea-hypopnea index (AHI).
RESULTS: CPAP was effective in all the patients (delta AHI 35.8 events/h; residual AHI 6.0 events/h). BP dramatically changed after a single-night CPAP and changes conformed to two well-distinguished patterns: pattern C (n = 29), characterized by consonant boxplots, and pattern D (n = 21), with variably discordant boxplots. The average number of comorbid diseases (1.55 [standard deviation, SD 1.0] in group C, 3.14 [SD 1.8] in group D, p < 0.001) and the prevalence of selected comorbidity (diabetes mellitus, metabolic syndrome, and chronic heart failure), were the only features distinguishing groups.
CONCLUSION: We found that BP change after a single night of CPAP largely depends upon comorbidity. Comorbidity likely contributes to phenotypic variability in OSAS population. BP might qualify as a surrogate index of the response to and, later, compliance with CPAP.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25323296     DOI: 10.1007/s11325-014-1065-y

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  15 in total

1.  Obstructive sleep apnea-hypopnea and neurocognitive functioning in the Sleep Heart Health Study.

Authors:  Stuart F Quan; Ron Wright; Carol M Baldwin; Kristine L Kaemingk; James L Goodwin; Tracy F Kuo; Alfred Kaszniak; Lori L Boland; Elise Caccappolo; Richard R Bootzin
Journal:  Sleep Med       Date:  2006-07-03       Impact factor: 3.492

2.  Predicting sleep apnea and excessive day sleepiness in the severely obese: indicators for polysomnography.

Authors:  John B Dixon; Linda M Schachter; Paul E O'Brien
Journal:  Chest       Date:  2003-04       Impact factor: 9.410

3.  Effects of continuous positive airway pressure therapy on systemic inflammation in obstructive sleep apnea: a meta-analysis.

Authors:  XiaoMei Xie; Lei Pan; DunQiang Ren; ChangJun Du; YongZhong Guo
Journal:  Sleep Med       Date:  2013-08-14       Impact factor: 3.492

4.  The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander.

Authors:  J Terán-Santos; A Jiménez-Gómez; J Cordero-Guevara
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

Review 5.  Obstructive sleep apnoea and cardiovascular disease.

Authors:  Manuel Sánchez-de-la-Torre; Francisco Campos-Rodriguez; Ferran Barbé
Journal:  Lancet Respir Med       Date:  2012-11-06       Impact factor: 30.700

6.  Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients.

Authors:  I Koutsourelakis; E Perraki; N T Economou; P Dimitrokalli; E Vagiakis; C Roussos; S Zakynthinos
Journal:  Eur Respir J       Date:  2009-04-08       Impact factor: 16.671

Review 7.  The oxygen therapy.

Authors:  A Corsonello; C Pedone; S Scarlata; A Zito; I Laino; R Antonelli-Incalzi
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

8.  Association of systematic head and neck physical examination with severity of obstructive sleep apnea-hypopnea syndrome.

Authors:  Adriane I Zonato; Lia Rita Bittencourt; Fernanda Louise Martinho; João Ferreira Santos Júnior; Luiz Carlos Gregório; Sergio Tufik
Journal:  Laryngoscope       Date:  2003-06       Impact factor: 3.325

Review 9.  Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.

Authors:  Luciano F Drager; Sônia M Togeiro; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho
Journal:  J Am Coll Cardiol       Date:  2013-06-12       Impact factor: 24.094

10.  A stepped approach for prediction of obstructive sleep apnea in overtly asymptomatic obese subjects: a hospital based study.

Authors:  S K Sharma; S Kurian; V Malik; A Mohan; A Banga; R M Pandey; K K Handa; S Mukhopadhyay
Journal:  Sleep Med       Date:  2004-07       Impact factor: 3.492

View more
  14 in total

Review 1.  Electronic Nose Technology in Respiratory Diseases.

Authors:  Silvano Dragonieri; Giorgio Pennazza; Pierluigi Carratu; Onofrio Resta
Journal:  Lung       Date:  2017-02-25       Impact factor: 2.584

2.  Short-term effects of a vibrotactile neck-based treatment device for positional obstructive sleep apnea: preliminary data on tolerability and efficacy.

Authors:  Simone Scarlata; Isaura Rossi Bartoli; Simona Santangelo; Gilda Giannunzio; Claudio Pedone; Raffaele Antonelli Incalzi
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 3.  Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases.

Authors:  Wadah Ibrahim; Liesl Carr; Rebecca Cordell; Michael J Wilde; Dahlia Salman; Paul S Monks; Paul Thomas; Chris E Brightling; Salman Siddiqui; Neil J Greening
Journal:  Thorax       Date:  2021-01-07       Impact factor: 9.139

4.  Sleep Apnea Syndrome Sensing at C-Band.

Authors:  Xiaodong Yang; Dou Fan; Aifeng Ren; Nan Zhao; Zhiya Zhang; Fangming Hu; Weigang Wang; Masood Ur Rehman; Jie Tian
Journal:  IEEE J Transl Eng Health Med       Date:  2018-11-01       Impact factor: 3.316

5.  Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.

Authors:  Vasiliki Besa; Helmut Teschler; Isabella Kurth; Amir Maqbul Khan; Paul Zarogoulidis; Joerg Ingo Baumbach; Urte Sommerwerck; Lutz Freitag; Kaid Darwiche
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-02-23

Review 6.  Dysfunctional adipose tissue and low-grade inflammation in the management of the metabolic syndrome: current practices and future advances.

Authors:  Marleen M J van Greevenbroek; Casper G Schalkwijk; Coen D A Stehouwer
Journal:  F1000Res       Date:  2016-10-13

Review 7.  Aging Airways: between Normal and Disease. A Multidimensional Diagnostic Approach by Combining Clinical, Functional, and Imaging Data.

Authors:  Mariaelena Occhipinti; Anna Rita Larici; Lorenzo Bonomo; Raffaele Antonelli Incalzi
Journal:  Aging Dis       Date:  2017-07-21       Impact factor: 6.745

8.  Multi-Sensor Approach for the Monitoring of Halitosis Treatment via Lactobacillus brevis (CD2)-Containing Lozenges--A Randomized, Double-Blind Placebo-Controlled Clinical Trial.

Authors:  Enrico Marchetti; Simona Tecco; Marco Santonico; Chiara Vernile; Daniele Ciciarelli; Ester Tarantino; Giuseppe Marzo; Giorgio Pennazza
Journal:  Sensors (Basel)       Date:  2015-08-10       Impact factor: 3.576

9.  Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study.

Authors:  Antonio De Vincentis; Giorgio Pennazza; Marco Santonico; Umberto Vespasiani-Gentilucci; Giovanni Galati; Paolo Gallo; Chiara Vernile; Claudio Pedone; Raffaele Antonelli Incalzi; Antonio Picardi
Journal:  Sci Rep       Date:  2016-05-05       Impact factor: 4.379

10.  Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.

Authors:  Panaiotis Finamore; Claudio Pedone; Simone Scarlata; Alessandra Di Paolo; Simone Grasso; Marco Santonico; Giorgio Pennazza; Raffaele Antonelli Incalzi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.